Subtopic Deep Dive
Drug Efflux Pumps in Intestinal Barrier
Research Guide
What is Drug Efflux Pumps in Intestinal Barrier?
Drug efflux pumps in the intestinal barrier are ATP-binding cassette (ABC) transporters, primarily P-glycoprotein (P-gp), that actively expel xenobiotics and drugs from enterocytes, limiting oral bioavailability and contributing to drug resistance.
These transporters, including MDR1/P-gp, BCRP, and MRP2, form a protective barrier against toxins in the gut lumen. Studies employ Caco-2 cell models, pharmacokinetic analyses, and in vivo imaging to quantify efflux impact on absorption. Over 10,000 papers cite key works like Giacomini et al. (2010, 3272 citations) on membrane transporters.
Why It Matters
Efflux pumps reduce oral bioavailability of 30-50% of clinical drugs, complicating chemotherapy delivery in oncology as shown by Alfarouk et al. (2015, 642 citations) on MDR mechanisms. Modulating P-gp with inhibitors like rifampin, per Greiner et al. (1999, 914 citations), enhances digoxin absorption and informs ADME predictions. Klaassen and Aleksunes (2010, 789 citations) detail bile acid regulation of these transporters, aiding therapies for metabolic diseases and NAFLD (Arab et al., 2016, 580 citations).
Key Research Challenges
Quantifying Efflux Contribution
Distinguishing efflux from metabolism and solubility in absorption models remains difficult. Caco-2 monolayers overestimate efflux, per Martinez and Amidon (2002, 625 citations). In vivo validation requires advanced imaging absent in most studies.
Bile Acid Transporter Interactions
Bile acids regulate ABC transporters via FXR signaling, complicating predictions (Li and Chiang, 2014, 873 citations). Variability in human vs. rodent expression hinders translation. Co-administration effects need pharmacokinetic modeling.
Species and Polymorphism Variability
P-gp polymorphisms alter drug interactions across populations (Greiner et al., 1999). Interspecies differences in transporter expression challenge preclinical models. Personalized medicine requires genotyping integration.
Essential Papers
Membrane transporters in drug development
Kathleen M. Giacomini, Shiew‐Mei Huang, Donald Tweedie et al. · 2010 · Nature Reviews Drug Discovery · 3.3K citations
The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
Bernd Greiner, Michel Eichelbaum, Péter Fritz et al. · 1999 · Journal of Clinical Investigation · 914 citations
Recent data point to the contribution of P-glycoprotein (P-gp) to digoxin elimination. On the basis of clinical observations of patients in whom digoxin levels decreased considerably when treated w...
Bile Acid Signaling in Metabolic Disease and Drug Therapy
Tiangang Li, John Y.L. Chiang · 2014 · Pharmacological Reviews · 873 citations
Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation
Curtis D. Klaassen, Lauren M. Aleksunes · 2010 · Pharmacological Reviews · 789 citations
Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
Khalid O. Alfarouk, C C Stock, Sophie Taylor et al. · 2015 · Cancer Cell International · 642 citations
Cancer chemotherapy resistance (MDR) is the innate and/or acquired ability of cancer cells to evade the effects of chemotherapeutics and is one of the most pressing major dilemmas in cancer therapy...
The blood-brain barrier: an engineering perspective
Andrew D. Wong, Mao Ye, Amanda F. Levy et al. · 2013 · Frontiers in Neuroengineering · 639 citations
It has been more than 100 years since Paul Ehrlich reported that various water-soluble dyes injected into the circulation did not enter the brain. Since Ehrlich's first experiments, only a small nu...
A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals
Marilyn N. Martinez, Gordon L. Amidon · 2002 · The Journal of Clinical Pharmacology · 625 citations
This article provides an overview of the patient‐specific and drug‐specific variables that can affect drug absorption following oral product administration. The oral absorption of any chemical enti...
Reading Guide
Foundational Papers
Start with Giacomini et al. (2010, 3272 citations) for transporter overview in drug development, then Greiner et al. (1999, 914 citations) for intestinal P-gp proof via digoxin-rifampin, and Klaassen and Aleksunes (2010, 789 citations) for regulation by bile acids.
Recent Advances
Study Li and Chiang (2014, 873 citations) on bile acid signaling in therapy, Alfarouk et al. (2015, 642 citations) on chemotherapy resistance via efflux, and Arab et al. (2016, 580 citations) linking to NAFLD.
Core Methods
Core techniques include Caco-2 permeability assays (Martinez and Amidon, 2002), pharmacokinetic modeling of DDI (Greiner et al., 1999), and FXR-mediated regulation studies (Li and Chiang, 2014).
How PapersFlow Helps You Research Drug Efflux Pumps in Intestinal Barrier
Discover & Search
Research Agent uses searchPapers('intestinal P-glycoprotein efflux digoxin rifampin') to retrieve Greiner et al. (1999, 914 citations), then citationGraph to map 500+ citing works on P-gp modulation, and findSimilarPapers to uncover Klaassen and Aleksunes (2010) on bile acid transporters.
Analyze & Verify
Analysis Agent applies readPaperContent on Giacomini et al. (2010) to extract ADME data, runPythonAnalysis for pharmacokinetic curve fitting from Caco-2 datasets, and verifyResponse with CoVe to cross-check efflux rates against GRADE B evidence from 3272-cited review.
Synthesize & Write
Synthesis Agent detects gaps in bile acid-efflux interactions via contradiction flagging across Li and Chiang (2014) and Arab et al. (2016); Writing Agent uses latexEditText for figure captions, latexSyncCitations to integrate 20 references, and latexCompile for barrier model diagrams via exportMermaid.
Use Cases
"Analyze P-gp efflux kinetics from Caco-2 data in Greiner et al. 1999"
Research Agent → searchPapers → Analysis Agent → readPaperContent + runPythonAnalysis (pandas curve fitting on digoxin-rifampin data) → matplotlib plot of efflux inhibition constants.
"Draft LaTeX review on ABC transporters in gut barrier with citations"
Synthesis Agent → gap detection → Writing Agent → latexEditText (insert Giacomini 2010 summary) → latexSyncCitations (add 15 refs) → latexCompile → PDF with intestinal barrier schematic.
"Find code for intestinal efflux pump simulations"
Research Agent → paperExtractUrls (Martinez 2002) → paperFindGithubRepo → githubRepoInspect → PK-Sim ODE solver code for P-gp mediated absorption modeling.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'intestinal efflux pumps bioavailability', structures report with GRADE grading on P-gp evidence from Giacomini et al. DeepScan applies 7-step CoVe to verify bile acid regulation claims from Klaassen and Aleksunes (2010). Theorizer generates hypotheses on rifampin-P-gp synergies from Greiner et al. (1999) citation clusters.
Frequently Asked Questions
What defines drug efflux pumps in the intestinal barrier?
ABC transporters like P-gp (MDR1) actively pump drugs from enterocytes back to the lumen, reducing bioavailability (Giacomini et al., 2010).
What methods study these pumps?
Caco-2 monolayers, Ussing chambers, and pharmacokinetic modeling quantify efflux; rifampin-digoxin interactions use clinical sampling (Greiner et al., 1999).
What are key papers?
Giacomini et al. (2010, 3272 citations) reviews transporters in development; Greiner et al. (1999, 914 citations) shows P-gp role in digoxin-rifampin interaction.
What open problems exist?
Predicting polymorphism effects on efflux and translating rodent models to humans; bile acid co-regulation needs multi-omics integration (Klaassen and Aleksunes, 2010).
Research Drug Transport and Resistance Mechanisms with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Drug Efflux Pumps in Intestinal Barrier with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers